Five reflections from 2025 and what they mean for commercial success in cell & gene therapy
10 Feb 2026
Theatre 1
Plenary
- Importance of building commercial infrastructure to scale beyond founder-led models.
- Clarity of messaging and the need to align communications with different stakeholder priorities.
- Strategic visibility and thought leadership to strengthen credibility and partnerships.
- Use of data and evidence—including patient-centric and real-world outcomes—to drive decision-making and market access.
- Early preparation and disciplined investment in systems, talent, and processes to support growth.
